Oral

Description: This Medical Care Section sponsored session present four diverse, but critically important assessments of important patient safety issues in both inpatient and outpatient settings. Adverse drug events in high risk patients is a common problem in health care that has significant morbidity and is responsible for many deaths. Prevention of such events would very likely save many lives and undoubtedly have be a major source of cost savings in the process. Knowledge of what interventions work could be of great value to providers taking care of high risk patients. E-prescribing is being implemented across the country and is mandated in the Afordable Care Act and it has shown its ability to prevent adverse events. Barriers remain to its use in clinics with limited resources. Identifying these barriers will promote positive outcomes and may ultimately improve the economics involved. Living Donor Kidney Transplants are the preferred type for patients in renal failure. However, as the numbers of such transplants increase, there are significant dangers and potential greater chances for error. Gathering information from staff that play a key role in this process can provide critical information in guarantee optimal outcomes. Deep vein thromboses and pulmonary emboli in the hospital setting care high morbidity and potential for mortality. There are known evidence based prevention methods that are not always implemented at all or implemented in a timely manner. In is important to understand why this may occur and what can be done to increase us of these methods.

Session Objectives: 1) Describe how the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC) assessed the basis for drug adverse events in high-risk patients, implemented interventions, and what improvements in safety were achieved as a result. 2) Describe the factors and solvable barriers to e-prescribing in small medical practices and safety net clinics serving Medicaid patients. 3) Identify the safety issues in Living Donor Kidney Transplant (LDKT) via safety debriefings of participating staff and the implication for policy to improve patient safety. 4) Identify gaps in the practice of evidence based Deep Vein Thrombosis (DVT)/ Pulmonary Embolism (PE) prophylaxis and methods to of using selected technologies to improve practice and thereby prevent adverse outcomes.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)